These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 35775551)

  • 21. MTBDRplus and MTBDRsl for simultaneous diagnosis of gastrointestinal tuberculosis and detection of first-line and second-line drug resistance.
    Sharma K; Sharma M; Sharma V; Sharma M; Parmar UPS; Samanta J; Sharma A; Kochhar R; Sinha SK
    J Gastroenterol Hepatol; 2023 Apr; 38(4):619-624. PubMed ID: 36652396
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecular Characteristic of Both Levofloxacin and Moxifloxacin Resistance in
    Zhang X; Chen X; Wang B; Fu L; Huo F; Gao T; Pang Y; Lu Y; Li Q
    Microb Drug Resist; 2022 Mar; 28(3):280-287. PubMed ID: 34981969
    [No Abstract]   [Full Text] [Related]  

  • 23. Re-evaluation of critical concentrations of antituberculosis fluoroquinolones in the Mycobacteria Growth Indicator Tube 960 system.
    Rupasinghe P; Driesen M; Vereecken J; de Jong BC; Rigouts L
    Int J Mycobacteriol; 2023; 12(3):316-323. PubMed ID: 37721239
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Detection and Molecular Analysis of Moxifloxacin MIC Values of Mycobacterium tuberculosis Strains Isolated from Clinical Specimens].
    Bozok T; Kayar B; Yakıcı G; Eker E; Marzi M; Karslı F; Köksal F
    Mikrobiyol Bul; 2019 Jul; 53(3):245-253. PubMed ID: 31414626
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Robustness of the Line Probe Assay for the Rapid Diagnosis and Characterization of Mutations in Extensively Drug-Resistant Tuberculosis.
    Ninan MM; Rupali P; James P; Michael JS
    Microb Drug Resist; 2019; 25(6):799-804. PubMed ID: 30785833
    [No Abstract]   [Full Text] [Related]  

  • 26. Frequency and geographic distribution of gyrA and gyrB mutations associated with fluoroquinolone resistance in clinical Mycobacterium tuberculosis isolates: a systematic review.
    Avalos E; Catanzaro D; Catanzaro A; Ganiats T; Brodine S; Alcaraz J; Rodwell T
    PLoS One; 2015; 10(3):e0120470. PubMed ID: 25816236
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparative study on genotypic and phenotypic second-line drug resistance testing of Mycobacterium tuberculosis complex isolates.
    van Ingen J; Simons S; de Zwaan R; van der Laan T; Kamst-van Agterveld M; Boeree MJ; van Soolingen D
    J Clin Microbiol; 2010 Aug; 48(8):2749-53. PubMed ID: 20554815
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The diagnostic accuracy of the GenoType(®) MTBDRsl assay for the detection of resistance to second-line anti-tuberculosis drugs.
    Theron G; Peter J; Richardson M; Barnard M; Donegan S; Warren R; Steingart KR; Dheda K
    Cochrane Database Syst Rev; 2014 Oct; (10):CD010705. PubMed ID: 25353401
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Specific gyrA Gene Mutations Correlate with High Prevalence of Discordant Levofloxacin Resistance in Mycobacterium tuberculosis Isolates from Beijing, China.
    Huo F; Ma Y; Li S; Xue Y; Shang Y; Dong L; Li Y; Pang Y
    J Mol Diagn; 2020 Sep; 22(9):1199-1204. PubMed ID: 32619641
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Detection by GenoType MTBDRsl test of complex mechanisms of resistance to second-line drugs and ethambutol in multidrug-resistant Mycobacterium tuberculosis complex isolates.
    Brossier F; Veziris N; Aubry A; Jarlier V; Sougakoff W
    J Clin Microbiol; 2010 May; 48(5):1683-9. PubMed ID: 20335420
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Performance of the MTBDRsl Line probe assay for rapid detection of resistance to second-line anti-tuberculosis drugs and ethambutol in China.
    Zeng X; Jing W; Zhang Y; Duan H; Huang H; Chu N
    Diagn Microbiol Infect Dis; 2017 Oct; 89(2):112-117. PubMed ID: 27345127
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Whole genome enrichment approach for rapid detection of Mycobacterium tuberculosis and drug resistance-associated mutations from direct sputum sequencing.
    Soundararajan L; Kambli P; Priyadarshini S; Let B; Murugan S; Iravatham C; Tornheim JA; Rodrigues C; Gupta R; Ramprasad VL
    Tuberculosis (Edinb); 2020 Mar; 121():101915. PubMed ID: 32279871
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of genetic correlation with fluoroquinolones resistance in rifampicin-resistant Mycobacterium tuberculosis isolates.
    Teng C; Li L; Su D; Li H; Zhao B; Xia H; Teng H; Song Y; Zheng Y; Cao X; Zheng H; Zhao Y; Ou X
    Heliyon; 2024 Jun; 10(11):e31959. PubMed ID: 38868072
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Multi- and Extensively Drug Resistant Mycobacterium tuberculosis in South Africa: a Molecular Analysis of Historical Isolates.
    Maningi NE; Daum LT; Rodriguez JD; Said HM; Peters RPH; Sekyere JO; Fischer GW; Chambers JP; Fourie PB
    J Clin Microbiol; 2018 May; 56(5):. PubMed ID: 29514936
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Induction in vitro and stability of Mycobacterium tuberculosis resistance to ofloxacin].
    Yang H; Hu Z; Sha W; Lu J; Cui Z; Wang J; Huang X; Xiao H
    Zhonghua Yu Fang Yi Xue Za Zhi; 2014 Apr; 48(4):318-23. PubMed ID: 24969458
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of a Rapid Molecular Drug-Susceptibility Test for Tuberculosis.
    Xie YL; Chakravorty S; Armstrong DT; Hall SL; Via LE; Song T; Yuan X; Mo X; Zhu H; Xu P; Gao Q; Lee M; Lee J; Smith LE; Chen RY; Joh JS; Cho Y; Liu X; Ruan X; Liang L; Dharan N; Cho SN; Barry CE; Ellner JJ; Dorman SE; Alland D
    N Engl J Med; 2017 Sep; 377(11):1043-1054. PubMed ID: 28902596
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Whole-genome analysis of drug-resistant Mycobacterium tuberculosis reveals novel mutations associated with fluoroquinolone resistance.
    Chaiyachat P; Chaiprasert A; Nonghanphithak D; Smithtikarn S; Kamolwat P; Pungrassami P; Reechaipichitkul W; Ong RT; Teo YY; Faksri K
    Int J Antimicrob Agents; 2021 Sep; 58(3):106385. PubMed ID: 34161790
    [TBL] [Abstract][Full Text] [Related]  

  • 38. gyrA mutations and phenotypic susceptibility levels to ofloxacin and moxifloxacin in clinical isolates of Mycobacterium tuberculosis.
    Sirgel FA; Warren RM; Streicher EM; Victor TC; van Helden PD; Böttger EC
    J Antimicrob Chemother; 2012 May; 67(5):1088-93. PubMed ID: 22357804
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genotype MTBDRsl line probe assay shortens time to diagnosis of extensively drug-resistant tuberculosis in a high-throughput diagnostic laboratory.
    Barnard M; Warren R; Gey Van Pittius N; van Helden P; Bosman M; Streicher E; Coetzee G; O'Brien R
    Am J Respir Crit Care Med; 2012 Dec; 186(12):1298-305. PubMed ID: 23087027
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Resistance Profiles to Second-Line Anti-Tuberculosis Drugs and Their Treatment Outcomes: A Three-Year Retrospective Analysis from South India.
    Gopalaswamy R; Palani N; Viswanathan D; Preysingh B; Rajendran S; Vijayaraghavan V; Thangavel K; Vadivel SD; Stanley H; Thiruvengadam K; Jayabal L; Murugesan K; Rathinam S; Frederick A; Sivaramakrishnan G; Padmapriyadarsini C; Shanmugam S
    Medicina (Kaunas); 2023 May; 59(6):. PubMed ID: 37374209
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.